RETROVIRUSES May 24 - 29, 2010
Abstract Deadline: March 5, 2010
[sb: Please also see the Invest in ME Conference Programme for May 24. For me, May 24 is the new Oct 8. So much research - hooray. Just a pity that they are on the same day.]
This meeting is now oversubscribed and new registrations will be waitlisted.
Organizers:
Christopher Aiken, Vanderbilt University
Jeremy Luban, University of Geneva, Switzerland
We are pleased to host the 35th annual meeting on Retroviruses which will begin at 7:30 p.m. on Monday May 24 and end after lunch on Saturday May 29, 2010.
We are looking forward to a broad-based meeting, and abstracts are welcomed on all aspects of retrovirology.
Tentative Topics:
Entry
Post-Entry
Assembly / Release
Integration
Reverse Transcription / Recombination
Pathogenesis / Host Factors
Transcription, RNA Processing, Export, Packaging
Antivirals
Keynote Speakers:
David Baltimore, California Institute of Technology
Ruslan Medzhitov, Yale University School of Medicine
Sandra Ruscetti, National Cancer Institute
Rayla Temin, University of Wisconsin-Madison
Abstracts should contain only new and unpublished material and must be submitted electronically by the abstract deadline. Selection of material for oral and poster presentation will be made by the organizers and individual session chairs. Status (talk/poster) of abstracts will be posted on our web site as soon as decisions have been made by the organizers.
This conference is supported in part by funds provided by National Institutes of Health and CSHL's Corporate Sponsor Program.
http://meetings.cshl.edu/meetings/retro10.shtml
-------------------------------------------------------------------------
Here is the link to the list of abstracts. I've copied over a few that look interesting. I probably missed others. Think there are over 300. Also interesting to see what rates a poster and what a talk.
http://meetings.cshl.edu/meetings/abstracts/2010retro_absstat.html
Aloia, A.L. Failure to detect XMRV in human prostate tumors poster
Bagni, R.K. Development of a multiplex serological assay to detect XMRV antibodies talk
Balasubramaniam, M. Host cell factors in retrovirus assembly and release talk
Bartels, H. Functional comparative analyses of glycosylated Gag molecules derived from different gammaretroviruses poster
Bego, M.G. Mechanisms of Type-I Interferon transcriptional regulation of Tetherin, a host factor restricting retrovirus release poster
Berger, G. Cell type specific antiviral effects of APOBEC3A during the early phases of lentiviral infection of myeloid cells and possible counteracting viral measures poster
Bhosle, S.M. Characterization of cellular determinants required for infection of XMRV, a novel retrovirus associated with human familial prostate cancer poster
Brown, C.A. Cytoskeletal regulatory proteins talin 1 and vinculin downregulate retroviral infection
talk
Bulliard, Y. Homologous loops contribute to the distinct antiviral activities of human APOBEC3A and APOBEC3G talk
Cingoz, O. Screening mouse genomes For XMRV-Like Elements talk
Das Gupta, J. Development of highly sensitive assays for the detection of XMRV nucleic acids in clinical samples poster
Gorzynski, J.E. Compounds that inhibit replication of XMRV, a virus implicated in prostate cancer and chronic fatigue syndrome talk
Gray, E. Investigation of XMRV as a human pathogen poster
Groom, H.C. Investigations into XMLV-related virus infection talk
Hanna, Z. XMRV is not detected in Quebec patients with chronic fatigue syndrome poster
Ikeda, Y. Wild-derived mouse strain (Mus pahari) as a small animal model for XMRV infection poster
Jensen, S.M. XMRV tropism in hematopoietic cells talk
Jones, K.S. Evidence for sequence variation in XMRV talk
Metzger, M.J. The human retrovirus XMRV produces rare transformation events in cell culture but does not have direct transforming activity talk
Paprotka, T. The XMRV is inhibited by APOBEC3 proteins and anti-HIV-1 drugs talk
Qiu, X. Immune responses in XMRV-infected rhesus macaquesSerological markers of XMRV infection poster
Rodriguez, J.J. XMRV Is inhibited by interferon independently of RNase L or Tetherin poster
Silverman, R.H. Comparison of XMRV infections in humans and rhesus macaques talk
Smith, R.A. Susceptibility of XMRV to antiretroviral inhibitors poster
Xu, W. Xpr1 is necessary but not sufficient for XMRV entry poster
Zhang, A. Effects of interferon regulated proteins, RNase L and APOBEC3G, on XMRV replication
poster
Abstract Deadline: March 5, 2010
[sb: Please also see the Invest in ME Conference Programme for May 24. For me, May 24 is the new Oct 8. So much research - hooray. Just a pity that they are on the same day.]
This meeting is now oversubscribed and new registrations will be waitlisted.
Organizers:
Christopher Aiken, Vanderbilt University
Jeremy Luban, University of Geneva, Switzerland
We are pleased to host the 35th annual meeting on Retroviruses which will begin at 7:30 p.m. on Monday May 24 and end after lunch on Saturday May 29, 2010.
We are looking forward to a broad-based meeting, and abstracts are welcomed on all aspects of retrovirology.
Tentative Topics:
Entry
Post-Entry
Assembly / Release
Integration
Reverse Transcription / Recombination
Pathogenesis / Host Factors
Transcription, RNA Processing, Export, Packaging
Antivirals
Keynote Speakers:
David Baltimore, California Institute of Technology
Ruslan Medzhitov, Yale University School of Medicine
Sandra Ruscetti, National Cancer Institute
Rayla Temin, University of Wisconsin-Madison
Abstracts should contain only new and unpublished material and must be submitted electronically by the abstract deadline. Selection of material for oral and poster presentation will be made by the organizers and individual session chairs. Status (talk/poster) of abstracts will be posted on our web site as soon as decisions have been made by the organizers.
This conference is supported in part by funds provided by National Institutes of Health and CSHL's Corporate Sponsor Program.
http://meetings.cshl.edu/meetings/retro10.shtml
-------------------------------------------------------------------------
Here is the link to the list of abstracts. I've copied over a few that look interesting. I probably missed others. Think there are over 300. Also interesting to see what rates a poster and what a talk.
http://meetings.cshl.edu/meetings/abstracts/2010retro_absstat.html
Aloia, A.L. Failure to detect XMRV in human prostate tumors poster
Bagni, R.K. Development of a multiplex serological assay to detect XMRV antibodies talk
Balasubramaniam, M. Host cell factors in retrovirus assembly and release talk
Bartels, H. Functional comparative analyses of glycosylated Gag molecules derived from different gammaretroviruses poster
Bego, M.G. Mechanisms of Type-I Interferon transcriptional regulation of Tetherin, a host factor restricting retrovirus release poster
Berger, G. Cell type specific antiviral effects of APOBEC3A during the early phases of lentiviral infection of myeloid cells and possible counteracting viral measures poster
Bhosle, S.M. Characterization of cellular determinants required for infection of XMRV, a novel retrovirus associated with human familial prostate cancer poster
Brown, C.A. Cytoskeletal regulatory proteins talin 1 and vinculin downregulate retroviral infection
talk
Bulliard, Y. Homologous loops contribute to the distinct antiviral activities of human APOBEC3A and APOBEC3G talk
Cingoz, O. Screening mouse genomes For XMRV-Like Elements talk
Das Gupta, J. Development of highly sensitive assays for the detection of XMRV nucleic acids in clinical samples poster
Gorzynski, J.E. Compounds that inhibit replication of XMRV, a virus implicated in prostate cancer and chronic fatigue syndrome talk
Gray, E. Investigation of XMRV as a human pathogen poster
Groom, H.C. Investigations into XMLV-related virus infection talk
Hanna, Z. XMRV is not detected in Quebec patients with chronic fatigue syndrome poster
Ikeda, Y. Wild-derived mouse strain (Mus pahari) as a small animal model for XMRV infection poster
Jensen, S.M. XMRV tropism in hematopoietic cells talk
Jones, K.S. Evidence for sequence variation in XMRV talk
Metzger, M.J. The human retrovirus XMRV produces rare transformation events in cell culture but does not have direct transforming activity talk
Paprotka, T. The XMRV is inhibited by APOBEC3 proteins and anti-HIV-1 drugs talk
Qiu, X. Immune responses in XMRV-infected rhesus macaquesSerological markers of XMRV infection poster
Rodriguez, J.J. XMRV Is inhibited by interferon independently of RNase L or Tetherin poster
Silverman, R.H. Comparison of XMRV infections in humans and rhesus macaques talk
Smith, R.A. Susceptibility of XMRV to antiretroviral inhibitors poster
Xu, W. Xpr1 is necessary but not sufficient for XMRV entry poster
Zhang, A. Effects of interferon regulated proteins, RNase L and APOBEC3G, on XMRV replication
poster